Equitable Holdings
EQH
$42.78
+0.47%
Equitable Holdings is a diversified financial services company operating primarily in the insurance and asset management sectors, providing retirement solutions, asset management, and wealth management services to individual and institutional clients. The company is a significant player in the annuities and retirement savings market, with its Retirement segment being the primary revenue driver, and also operates a global asset management business through its subsidiary AB. The current investor narrative centers on the company's capital return strategy, highlighted by recent substantial share repurchase announcements, which signal management confidence but also occur against a backdrop of volatile quarterly earnings performance, particularly a significant net loss in Q3 2025, raising questions about underlying operational stability and growth.…
EQH
Equitable Holdings
$42.78
Related headlines
Investment Opinion: Should I buy EQH Today?
Rating: Hold. The core thesis is that while EQH is fundamentally unstable and risky, its deeply depressed valuation and aggressive capital return program create a balanced, speculative opportunity that is only suitable for risk-tolerant investors, warranting a neutral stance.
The Hold rating is anchored by the unanimous 'Overweight/Buy' analyst consensus, yet tempered by severe fundamental risks. Supporting evidence includes: 1) A low forward Price-to-Sales ratio of ~0.80 based on analyst revenue estimates, suggesting deep value. 2) Positive TTM free cash flow of $737 million funding shareholder returns. 3) A high Return on Equity of 18.65% indicating capital efficiency potential. 4) A current price 24.8% below the 52-week high, reflecting significant pessimism already baked in.
The two biggest risks that could invalidate this thesis are another quarter of massive net losses eroding book value, and a sustained breakdown below the $35.20 support level triggering technical selling. This Hold would upgrade to a Buy if the company reports two consecutive quarters of stable, positive net income, confirming Q3 2025 was an anomaly. It would downgrade to a Sell if revenue declines further below the Q4 level or if free cash flow turns negative. Relative to its history and battered peers, the stock appears fairly valued for its high-risk profile—neither compellingly cheap nor egregiously expensive.
Sign up to view all
EQH 12-Month Price Forecast
EQH presents a classic 'value trap' versus 'deep value turnaround' dilemma. The neutral stance reflects the high probability (50%) of a continued range-bound, volatile trajectory. The bullish analyst consensus and capital returns provide a floor, but the extreme operational instability creates a formidable ceiling. Confidence is medium because the key variable—quarterly earnings predictability—is currently unobservable and historically poor. The stance would upgrade to bullish upon evidence of two consecutive clean quarters, confirming the Q3 loss was non-recurring. It would downgrade to bearish if the stock breaks below $35.20 on high volume, signaling a failure of the buyback support thesis.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Equitable Holdings's 12-month outlook, with a consensus price target around $55.61 and implied upside of +30.0% versus the current price.
Average Target
$55.61
2 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
2
covering this stock
Price Range
$34 - $56
Analyst target range
Analyst coverage appears limited with only 2 analysts providing estimates, but institutional ratings from major firms show consistent bullish sentiment. Recent ratings from Morgan Stanley, Wells Fargo, UBS, JP Morgan, and Barclays all maintain 'Overweight' or 'Buy' equivalents, with JP Morgan upgrading from Neutral to Overweight in January 2026, indicating strengthening conviction among covering institutions. The wide range in EPS estimates, from a low of $10.52 to a high of $13.39, signals significant uncertainty about the company's earnings power, which is understandable given the volatile quarterly results; however, the unanimous bullish ratings from major firms suggest analysts believe the current depressed price and capital return actions outweigh the near-term operational volatility.
Bulls vs Bears: EQH Investment Factors
The investment debate for EQH centers on a stark conflict between valuation/sentiment and fundamental stability. The bull case, supported by strong analyst ratings, aggressive buybacks, and seemingly cheap valuation multiples, currently holds stronger evidence from a capital allocation and contrarian perspective. However, the bear case presents overwhelming evidence of operational dysfunction, with extreme quarterly volatility in earnings and margins that cannot be ignored. The single most important tension is whether management's capital return strategy and the company's cash-generating ability can sustainably outweigh the severe and recurring operational instability. The resolution of this tension—specifically, whether Q3 2025's massive loss was an anomaly or a symptom of a deeper problem—will determine the investment thesis.
Bullish
- Strong Capital Return via Buybacks: Recent substantial share repurchase announcements signal management confidence and provide a direct EPS tailwind. This capital allocation strategy is a key focus for investors, as highlighted by recent news, and supports shareholder value despite operational volatility.
- Attractive Valuation Metrics: The stock trades at a trailing PS ratio of 1.22 and an implied forward PS of ~0.80 based on analyst revenue estimates, which is low for the financial services sector. This suggests a significant market discount, potentially offering a margin of safety if operations stabilize.
- Unanimous Bullish Analyst Sentiment: Major institutions including JP Morgan, Morgan Stanley, and Barclays maintain 'Overweight' or 'Buy' ratings, with JP Morgan recently upgrading from Neutral. This consensus indicates professional conviction that the depressed price and capital returns outweigh near-term volatility.
- Positive Free Cash Flow Generation: The company generated $737 million in TTM free cash flow, demonstrating an ability to produce cash from operations. This cash flow underpins the capital return strategy and provides financial flexibility despite earnings instability.
Bearish
- Extreme Earnings and Margin Volatility: Profitability is highly erratic, with Q3 2025 showing a net loss of $1.31 billion and a gross margin of -17.0%, swinging to a net income of $215 million and an 88.1% gross margin in Q4. This instability makes forecasting difficult and raises concerns about operational control.
- Severe Underperformance vs. Market: The stock has a 1-year price change of -19.43%, underperforming the SPY by a staggering 44.6 percentage points. This deep underperformance reflects a loss of investor confidence and persistent negative momentum, with a 52-week high of $56.61 now 24.8% above the current price.
- Weak Balance Sheet Indicators: The company shows a highly negative debt-to-equity ratio of -88.68 and a weak current ratio of 0.57, indicating a complex capital structure and potential near-term liquidity constraints despite positive cash flow.
- Inconsistent and Declining Revenue: Revenue growth is inconsistent, with Q4 2025 revenue of $3.28 billion representing a -9.5% year-over-year decline. Quarterly revenue has fluctuated wildly from $3.90B to $1.45B, indicating fundamental instability in the core business.
EQH Technical Analysis
The stock is in a pronounced downtrend, with a 1-year price change of -19.43%, significantly underperforming the SPY's +25.19% gain. Currently trading at $42.58, it sits near the lower end of its 52-week range, approximately 12.5% above the 52-week low of $35.195 and 24.8% below the 52-week high of $56.61, indicating the stock is in a depressed state that could represent a value opportunity or reflect ongoing fundamental concerns. Recent momentum shows a slight 1-month gain of 1.38%, which contrasts sharply with the 3-month decline of -4.08% and the deeper 6-month drop of -4.79%, suggesting a potential stabilization or minor bounce from oversold levels, though this nascent positive momentum remains fragile within the broader bearish context. Key technical support is clearly defined at the 52-week low of $35.195, while resistance lies at the 52-week high of $56.61; a sustained breakdown below $35.20 would signal a new leg down, whereas a move above the recent high near $49.25 is needed to suggest a meaningful reversal. With a beta of 1.13, the stock exhibits moderately higher volatility than the broader market, which is consistent with its financial sector exposure and earnings volatility.
Beta
1.13
1.13x market volatility
Max Drawdown
-37.0%
Largest decline past year
52-Week Range
$35-$57
Price range past year
Annual Return
-20.2%
Cumulative gain past year
| Period | EQH Return | S&P 500 |
|---|---|---|
| 1m | +2.5% | +4.0% |
| 3m | -5.5% | +8.2% |
| 6m | -2.8% | +11.5% |
| 1y | -20.2% | +24.3% |
| ytd | -10.8% | +8.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
EQH Fundamental Analysis
Revenue growth is inconsistent and recently negative, with Q4 2025 revenue of $3.28 billion representing a -9.5% year-over-year decline, and the quarterly income statements reveal extreme volatility, from a $3.90 billion revenue in Q1 2025 to a $1.45 billion revenue in Q3 2025. The company's profitability is highly erratic, swinging from a net income of $215 million in Q4 2025 to a massive net loss of $1.31 billion in Q3 2025, while the gross margin has fluctuated wildly from 88.1% in Q4 2025 to -17.0% in Q3 2025, indicating severe operational instability and challenges in managing investment-related costs. The balance sheet and cash flow picture is mixed; the company generated positive free cash flow on a TTM basis ($737 million) and reported a strong Return on Equity of 18.65%, but it also shows a highly negative debt-to-equity ratio of -88.68 and a weak current ratio of 0.57, suggesting a complex capital structure with potential liquidity constraints despite overall cash generation.
Quarterly Revenue
$3.3B
2025-12
Revenue YoY Growth
-0.09%
YoY Comparison
Gross Margin
+0.88%
Latest Quarter
Free Cash Flow
$737000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is EQH Overvalued?
Given the trailing twelve-month net income is negative ($-0.097 EPS), the primary valuation metric selected is the Price-to-Sales (PS) ratio. The trailing PS ratio is 1.22, while the forward-looking valuation can be inferred from analyst estimates, with an average revenue estimate of $17.78 billion implying a forward PS of approximately 0.80 based on the current market cap, indicating the market expects revenue growth to improve efficiency. Compared to sector averages, a PS ratio around 1.2 is generally low for a financial services firm with asset management and insurance operations, suggesting the market is applying a significant discount, likely due to the extreme earnings volatility and net losses reported in recent quarters. Historically, the stock's own PS ratio has ranged dramatically, from as high as 12.28 in Q1 2021 to the current 1.22; the current level is near the lower end of its historical range, which could indicate a valuation floor if operations stabilize, but also reflects the market's severe discounting of the company's recent fundamental deterioration.
PE
-10.3x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -25x~64x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-8.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are pronounced. The company's profitability is highly volatile, with a net loss of $1.31 billion in Q3 2025 swinging to a $215 million profit in Q4, making earnings visibility poor. The negative debt-to-equity ratio of -88.68 and a weak current ratio of 0.57 suggest a complex and potentially strained capital structure, despite generating $737M in TTM free cash flow. Revenue concentration risk is evident as the Retirement segment drives most revenue, and its performance has been inconsistent, with Q4 revenue declining 9.5% YoY.
Market & Competitive Risks include severe valuation compression, as the stock's -19.4% 1-year return and -44.6% relative underperformance versus the SPY demonstrate a loss of market favor. With a beta of 1.13, the stock exhibits higher volatility than the market, amplifying downside during sector-wide selloffs in financials. The primary competitive risk is that persistent operational volatility erodes client and investor confidence in its retirement and asset management offerings, leading to asset outflows. The stock trades at a significant discount (PS of 1.22) to its own historical highs (PS over 12), indicating the market has already priced in substantial deterioration.
The Worst-Case Scenario involves a failure to stabilize operations, leading to another quarter with catastrophic investment losses similar to Q3 2025. This could trigger a crisis of confidence, analyst downgrades reversing the current bullish consensus, and accelerated asset outflows from its core segments. The realistic downside is quantified by the 52-week low of $35.195, which is approximately 17.4% below the current price of $42.58. A breach of this level could lead to a test of the stock's maximum drawdown level of -37%, implying a potential loss from current levels in the range of -20% to -35% in a prolonged adverse scenario.
FAQ
The key risks are, in order of severity: 1) Operational & Earnings Risk: The potential for a repeat of the Q3 2025 $1.31 billion net loss, as quarterly profitability has swung wildly from -$1.31B to +$215M. 2) Financial Structure Risk: A highly negative debt-to-equity ratio (-88.68) and weak current ratio (0.57) indicate balance sheet complexity and liquidity constraints. 3) Market & Sentiment Risk: The stock has underperformed the SPY by 44.6% over the past year, and a loss of the current bullish analyst consensus could trigger further de-rating. 4) Revenue Risk: Inconsistent and recently declining revenue, with Q4 2025 down 9.5% YoY, questions the stability of its core retirement and asset management businesses.
The 12-month forecast is highly bifurcated, with a base case (50% probability) target range of $42-$48, implying minimal movement from the current $42.58 price. The bull case (25% probability) targets $52-$58, driven by operational stabilization and successful buyback execution. The bear case (25% probability) warns of a drop to $32-$38 if another major quarterly loss occurs. The most likely scenario is the base case of continued range-bound volatility, as the company's recent history does not provide confidence for a sustained breakout in either direction. The key assumption behind the base forecast is that free cash flow remains positive, funding capital returns, while earnings volatility prevents a meaningful re-rating.
EQH appears fairly valued relative to its current high-risk profile. It trades at a trailing Price-to-Sales ratio of 1.22, which is low for the financial services sector and near the bottom of its own historical range (which has exceeded 12). This deep discount is justified by negative trailing profitability (EPS of -$0.097, net margin of -11.8%). The forward PS of ~0.80, based on analyst revenue estimates, suggests the market is pricing in significant skepticism. The valuation implies the market expects continued operational challenges and does not believe recent quarterly losses are fully in the past. It is not clearly undervalued without evidence of sustained fundamental improvement.
EQH is a speculative buy only for risk-tolerant investors. The stock offers a potential 22-36% upside to the analyst-implied bull case target (~$52-$58), supported by unanimous bullish institutional ratings and aggressive share buybacks. However, this is counterbalanced by a severe 17-35% downside risk to the 52-week low and below, driven by extreme earnings volatility exemplified by a $1.31 billion quarterly net loss. It is not a good buy for conservative, income-focused, or short-term investors. It may suit a contrarian value investor's portfolio as a high-risk satellite holding, provided they can withstand significant volatility.
EQH is unsuitable for short-term trading due to its high beta (1.13) and extreme earnings volatility, which can cause sharp, unpredictable price swings around quarterly reports. It is only a candidate for a medium-to-long-term (2+ year) investment for investors betting on a fundamental turnaround. This longer horizon is necessary to see if management's capital return strategy can succeed in stabilizing the stock while the underlying business cycles improve. The lack of a meaningful dividend yield (2.64%) and low earnings visibility further detract from its appeal as a long-term income or core growth holding. A minimum holding period of 18-24 months is suggested to properly evaluate the success of the stabilization thesis.
